# XORTX Therapeutics Inc.: financial statements, quarterly

XRTX · Nasdaq · CIK 1729214 · [Healthcare](/sectors/healthcare.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/xrtx.md) · [Financials](/companies/xrtx/financials.md) · [Filings](/companies/xrtx/filings.md) · [Insiders](/companies/xrtx/insiders.md)

Standardized line items from XBRL company facts. Each value links to its filing; d marks a value derived from year-to-date figures. Other view: [annual](/companies/xrtx/financials.md?period=annual).

## Balance sheet

| Line item | Unit | period not labelled (2018-12-31) | period not labelled (2019-12-31) | period not labelled (2020-12-31) | FY2021 (2021-12-31) |
| --- | --- | ---: | ---: | ---: | ---: |
| Cash and equivalents | $m | [0.3](/filings/0001753926-22-000646.md) | [0.1](/filings/0001753926-22-000646.md) | [0.2](/filings/0001753926-22-000646.md) | [18.9](/filings/0001753926-22-000646.md) |
| Current assets | $m | not reported | not reported | [2.1](/filings/0001753926-22-000646.md) | [20.2](/filings/0001753926-22-000646.md) |
| Total assets | $m | not reported | not reported | [2.3](/filings/0001753926-22-000646.md) | [22.0](/filings/0001753926-22-000646.md) |
| Current liabilities | $m | not reported | not reported | [1.0](/filings/0001753926-22-000646.md) | [0.7](/filings/0001753926-22-000646.md) |
| Total liabilities | $m | not reported | not reported | [1.0](/filings/0001753926-22-000646.md) | [5.3](/filings/0001753926-22-000646.md) |
| Shareholders' equity | $m | [0.3](/filings/0001753926-22-000646.md) | [(0.2)](/filings/0001753926-22-000646.md) | [1.3](/filings/0001753926-22-000646.md) | [16.7](/filings/0001753926-22-000646.md) |

- Cash and equivalents: ifrs-full:CashAndCashEquivalents
- Current assets: ifrs-full:CurrentAssets
- Total assets: ifrs-full:Assets
- Current liabilities: ifrs-full:CurrentLiabilities
- Total liabilities: ifrs-full:Liabilities
- Shareholders' equity: ifrs-full:Equity, ifrs-full:EquityAttributableToOwnersOfParent

Shares outstanding: 12,989,678 at 2021-12-31, from the cover of the [20-F/A filed 2023-01-27](/filings/0001104659-23-007121.md) (dei:EntityCommonStockSharesOutstanding).

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:46 ET. No prices; not investment advice.